Raymond Debbane

Director, Lexicon Pharmaceuticals, Inc.

Bought, 12 months

$0.7M

Sold, 12 months

$0.0M

Companies

Latest trade

Feb 25, 2026

Companies

Lexicon Pharmaceuticals, Inc.Director +$0.7M

Trades

LXRX Bought 2,000 shares at $1.49 $0.0M Feb 25

LXRX Bought 100,000 shares at $1.47 $0.1M Feb 23

LXRX Bought 100,000 shares at $1.48 $0.1M Feb 20

LXRX Bought 50,000 shares at $1.44 $0.1M Feb 19

LXRX Bought 133,688 shares at $1.32 $0.2M Feb 18

LXRX Bought 76,857 shares at $1.31 $0.1M Feb 17

LXRX Bought 57,952 shares at $1.31 $0.1M Feb 13

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.